Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Cells ; 10(12)2021 11 24.
Article in English | MEDLINE | ID: mdl-34943801

ABSTRACT

Chronic hypoxia increases the resistance of pulmonary arteries by stimulating their contraction and augmenting their coverage by smooth muscle cells (SMCs). While these responses require adjustment of the vascular SMC transcriptome, regulatory elements are not well defined in this context. Here, we explored the functional role of the transcription factor nuclear factor of activated T-cells 5 (NFAT5/TonEBP) in the hypoxic lung. Regulatory functions of NFAT5 were investigated in cultured artery SMCs and lungs from control (Nfat5fl/fl) and SMC-specific Nfat5-deficient (Nfat5(SMC)-/-) mice. Exposure to hypoxia promoted the expression of genes associated with metabolism and mitochondrial oxidative phosphorylation (OXPHOS) in Nfat5(SMC)-/- versus Nfat5fl/fl lungs. In vitro, hypoxia-exposed Nfat5-deficient pulmonary artery SMCs elevated the level of OXPHOS-related transcripts, mitochondrial respiration, and production of reactive oxygen species (ROS). Right ventricular functions were impaired while pulmonary right ventricular systolic pressure (RVSP) was amplified in hypoxia-exposed Nfat5(SMC)-/- versus Nfat5fl/fl mice. Scavenging of mitochondrial ROS normalized the raise in RVSP. Our findings suggest a critical role for NFAT5 as a suppressor of OXPHOS-associated gene expression, mitochondrial respiration, and ROS production in pulmonary artery SMCs that is vital to limit ROS-dependent arterial resistance in a hypoxic environment.


Subject(s)
Hypoxia/pathology , Lung/pathology , Mitochondria/metabolism , Myocytes, Smooth Muscle/metabolism , Pulmonary Artery/pathology , Reactive Oxygen Species/metabolism , Transcription Factors/metabolism , Vascular Resistance , Animals , Blood Pressure , Electrocardiography , Gene Expression Regulation , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Metabolome , Mice , Myocytes, Smooth Muscle/pathology , Oxidative Phosphorylation , Oxygen Consumption , Protein Transport , Systole , Transcription Factors/deficiency , Vascular Resistance/genetics
2.
Cancer Lett ; 469: 238-245, 2020 01 28.
Article in English | MEDLINE | ID: mdl-31678166

ABSTRACT

The therapy resistance of pancreatic cancer is associated with the loss of gap junction intercellular communication and connexin 43 expression. The broccoli isothiocyanate sulforaphane restored these features and therapy sensitivity. We investigated whether microRNA signaling is involved. Established cell lines and a patient tissue array (n = 96) were evaluated by miRNA and gene array, bioinformatics, expression studies, in situ hybridization and immunohistochemistry. Sulforaphane inhibited the expression of our top candidate miR30a-3p. Upon transfection of miR30a-3p inhibitors, the gemcitabine bystander effect, Cx43 expression and intercellular communication increased, whereas miR30a-3p mimics inhibited the luciferase activity of a Cx43 3'-UTR construct. miR30a-3p-overexpressing tumor xenografts had a decreased tumor volume and increased gemcitabine sensitivity. In patient tissues, a higher expression of miR30a-3p and a lower expression of Cx43 correlated with malignancy. These findings provide new knowledge and suggest sulforaphane as cotreatment for pancreatic cancer.


Subject(s)
Connexin 43/genetics , Isothiocyanates/pharmacology , MicroRNAs/genetics , Pancreatic Neoplasms/drug therapy , Adult , Aged , Animals , Cell Communication/drug effects , Cell Line, Tumor , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacology , Female , Gap Junctions/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Heterografts , Humans , In Situ Hybridization , Male , Mice , Middle Aged , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Signal Transduction/drug effects , Sulfoxides , Gemcitabine
3.
Cell Death Dis ; 10(10): 760, 2019 10 07.
Article in English | MEDLINE | ID: mdl-31591378

ABSTRACT

Melanoma immunotherapy is still not satisfactory due to immunosuppressive cell populations within the tumor stroma. Targeting tumor-associated macrophages (TAM) can help to restore an anti-tumor immunity. Previously, we could show that classical TAM markers expressed in vivo need a 7 day M-CSF/dexamethasone/IL-4 (MDI) stimulation for their induction in peripheral blood monocytes (pBM) in vitro. To identify possible novel therapeutic targets on TAM, gene expression analysis of MDI-treated pBM was performed. This identified up-regulation of the purinergic G-protein coupled receptor P2Y12, the therapeutic target of the clinically approved anti-thrombotic drugs cangrelor, clopidogrel, ticagrelor, and prasugrel. We generated a peptide antibody and validated its specificity using transgenic P2Y12+ U937 cells. With the help of this antibody, P2Y12 expression was confirmed on CD68+ CD163+ TAM of melanoma in situ. Functional analysis revealed that treatment of transgenic P2Y12+ U937 cells with the receptor agonist 2-MeSADP induced ERK1/2 and Akt phosphorylation and increased the secretion of the chemokines CXCL2, CXCL7, and CXCL8. These effects could be abolished with the P2Y12 antagonist PSB0739 or with Akt and ERK inhibitors. In addition, P2Y12+ macrophages migrated towards the ADP-rich culture medium of puromycin-treated dying B16F1 melanoma cells. Cangrelor treatment blocked migration. Taken together, our results indicate that P2Y12 is an important chemotaxis receptor, which triggers migration of macrophages towards nucleotide-rich, necrotic tumor areas, and modulates the inflammatory environment upon ADP binding.


Subject(s)
Chemokines/genetics , Chemotaxis/drug effects , Melanoma/drug therapy , Receptors, Purinergic P2Y12/genetics , Adenosine Diphosphate/biosynthesis , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/pharmacology , Cell Line, Tumor , Chemokine CXCL2/genetics , Chemotaxis/genetics , Clopidogrel/pharmacology , Dexamethasone/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Humans , Interleukin-4/pharmacology , Interleukin-8/genetics , MAP Kinase Signaling System/drug effects , Macrophage Colony-Stimulating Factor/pharmacology , Macrophages/drug effects , Melanoma/genetics , Melanoma/pathology , Monocytes/drug effects , Phosphorylation/drug effects , Prasugrel Hydrochloride/pharmacology , Ticagrelor/pharmacology , beta-Thromboglobulin/genetics
4.
Psicol. rev ; (3): 75-87, nov. 1996.
Article in Spanish | Index Psychology - journals | ID: psi-18657

ABSTRACT

A partir de sua vivência e contatos diretos e indiretos com a Psicologia Soviética, tendo como contraponto a produção vygotskyana e sua contribuição para a Psicologia Científica Marxista, os autores fazem uma reflexão sobre as etapas do desenvolvimento da Psicologia na antiga União Soviética, desde seus primórdios até a época atual. Identificam quatro momentos na história da Psicologia Soviética assim caracterizados: a busca {compreendendo desde a Revolução Comunista até os anos trinta}, a instauração {entre os anos trinta e sessenta}, a estabilização {entre os anos sessenta e oitenta} e, a dissolução {fim dos anos oitenta e início dos noventa}. Por meio dessa leitura histórica procuram responder questões como: De que Psicologia Soviética se fala? Onde se encontra Vygotsky nessa Psicologia? E o que resta dessa Psicologia? (AU)

SELECTION OF CITATIONS
SEARCH DETAIL
...